RecruitingNCT02863172

Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes


Sponsor

M.D. Anderson Cancer Center

Enrollment

2,000 participants

Start Date

May 22, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

Objectives: 1. To examine the variations in clinical features, survival outcomes, family history, and health behavior among proband patients who are known or suspected to have a hereditary colorectal cancer syndrome 2. To compare the clinical features, survival outcomes, and health behavior of the proband vs. his/her family members who may or may not be affected by the hereditary colorectal cancer syndrome 3. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in the overall disease phenotype across probands and kindreds, within a given syndrome. Disease phenotype is defined to include: (1) clinicopathologic features including patient demographics and oncologic outcomes; (2) clinical manifestations of disease including the timing, spectrum and severity of CRC and extracolonic cancers. Genetic variations may include the specific codon mutated, the type of mutation and sequence alteration (e.g. nonsense, missense etc), chromosomal/gene copy number changes, and gene polymorphisms. 4. To explore for correlations between germline genetic variations in both the probands and family members with observed variations in somatic CRC tumor biology, including tumor pathology and other tumor molecular markers


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting genetic and clinical data from patients and their family members who have or are suspected to have a hereditary colorectal cancer syndrome — an inherited condition that greatly increases the risk of colon cancer — to better understand these syndromes at a molecular level. **You may be eligible if...** - You are 18 or older - You have or are suspected to have a hereditary colorectal cancer syndrome - You have a sufficient understanding of English and can provide informed consent - Or you are a first- or second-degree relative (parent, sibling, child, grandparent, or aunt/uncle) of a qualifying patient at MD Anderson Cancer Center **You may NOT be eligible if...** - There are no exclusion criteria for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALQuestionnaires

Consenting Proband Group: Participants fill out questionnaires about work, family history, medical history, and health habits at baseline. It should take about 20 minutes to complete the questionnaires. Participants also complete a health and lifestyle questionnaire, which contains 20 questions for men and 22 questions for women. Questionnaire should take about 10 minutes to complete. Follow-up questionnaire at least 1 time in 5 years to update medical, cancer, and family history. Family Members (MDA Registered Patients) Group and Family Members (Not MDA Registered Patients) Group: Participants complete a health questionnaire, which collects information about their personal medical history, demographics (age, race, sex, and so on), and questions about their alcohol and tobacco use at baseline. Questionnaire should take about 20 minutes to complete. Participants complete follow-up questionnaire at least 1 time in 5 years to update their medical, cancer, and family history.

PROCEDUREBlood Draw/Saliva Sample

About 2-3 tablespoons blood drawn. Participants may give a saliva sample instead.


Locations(1)

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02863172